Invesaro

Stocks PZZA Financial statements

Financial statements

PAPA JOHNS INTERNATIONAL INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PAPA JOHNS INTERNATIONAL INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Revenue1,7141,7831,6631,6191,8132,0682,1022,1362,0592,054
Cost of revenue1,5581,5581,4781,460
Gross profit544577581593
General and administrative158151194223204212215208191244
Operating income16515131.624.590.316810914715789.1
Interest expense7.411.325.720.61719.226.7
Interest income0.790.610.821.12.131.91
Pre-tax income1591406.75.0548.611583.810411448.4
Income tax49.733.82.62-0.6114.72614.420.929.916.3
Net income to minority interests4.941.580.70.711.59
Net income1031022.474.8757.912067.882.183.530.5
EBITDA2061957871.8140217161211226181
EPS, basic2.762.860.08-0.241.290.121.902.492.550.90
EPS, diluted2.742.830.08-0.241.280.121.892.482.540.90
Shares, basic (weighted)37.336.132.131.632.43535.532.932.732.9
Shares, diluted (weighted)37.636.532.331.632.735.335.733.232.832.9
Dividend per share0.750.850.900.900.901.151.541.761.841.84

Balance sheet

FY2016FY2017FY2018FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents15.622.333.327.913070.647.440.63834.6
Receivables59.664.678.170.590.181.4103104102103
Inventory25.130.627.227.530.33541.436.135.234.3
Other current assets9.049.495.6843.843.246.344.142.348.648.9
Total current assets146170196182306255251231231237
Property, plant and equipment230234227212201224250283273251
Lease right-of-use assets148148176172164184162
Goodwill85.586.984.580.380.880.670.676.275.567.6
Other non-current assets40.148.263.864.672.488.474.276.787.677.3
Total assets513556596731873886864875889838
Accounts payable42.73227.129.137.428.162.374.961.861.2
Accrued liabilities76.815.41324.646.448.721.936.533.241.4
Deferred revenue6.0217.719.621.721.320.415.513.1
Short-term debt202020200005
Total current liabilities128133189208289287265305278291
Long-term debt300447601347328481597757742710
Lease liabilities125125161161151174156
Other non-current liabilities53.160.179.384.911193.268.360.264.962.3
Total liabilities4946558947908811,0531,1341,3181,3021,270
Total debt300467621367348481597757742722
Paid-in capital173185193219254445450452452457
Retained earnings219292242206219183196219242211
Treasury stock-390-597-752-747-742-806-922-1,123-1,116-1,107
Other comprehensive income-5.89-2.12-3.14-10.2-14.2-9.97-10.1-7.8-8.46-6.45
Shareholders' equity-3.91-122-319-332-282-188-286-459-430-445
Minority interests13.715.815.215.715.215.215.715.515.311.1
Total equity9.8-106-304-317-267-172-271-444-414-434
Total liabilities and equity513556596731873886864875889838
Shares outstanding36.733.931.431.932.535.834.732.532.632.8

Cash flow statement

FY2016FY2017FY2018FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Net income1091074.075.6660.612569.382.884.232.1
Depreciation and amortization4143.746.447.349.748.85264.169.492.2
Stock-based compensation10.110.49.9415.316.316.918.417.99.5915
Deferred income tax11.60.51.62-3.76-9.273.752.8-5.99-3.046.74
Change in receivables1.56-7.362.16-6.18-22.44.02-28.6-4.92-0.47-7.56
Change in inventory-3.64-5.493.09-0.33-2.74-4.71-7.55.440.850.02
Change in payables-0.92-8.74-0.42.048.23-9.281.1222-10-0.62
Cash from operations15013592.561.7186185118193107126
Capital expenditures-55.6-52.6-42-37.7-35.7-68.6-78.4-76.6-72.5-64.7
Acquisitions-13.4-0.020-0.7-1.22-5.61-0.130
Cash from investing-46.3-56.5-38.8-32.6-41.1-63.5-62.8-75.1-17.3-21.5
Stock issued7.066.262.71630.6124.042.251.060.41
Share buybacks-122-210-158-2.7-72.5-125-210-2.080
Dividends paid-27.9-30.7-29-28.6-29.4-40.4-54.8-58.5-60.6-61.1
Cash from financing-109-72.1-48.1-34.6-43.5-181-76.2-124-91.7-106
Exchange rate effect-0.40.37
Net change in cash-5.446.785.37-5.35102-59.6-23.2-6.79-2.63-1.01
Free cash flow94.782.450.42415111639.411634.161.3
Interest paid7.110.823.518.115.813.424.437.341.139.9
Income taxes paid35.137.214-6.219.332.611.712.536.316.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $19.55 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin28.7%Gross profit / revenue.
Operating margin4.3%Operating income / revenue.
EBITDA margin9.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin2.3%Pre-tax income / revenue.
Net margin1.4%Net income / revenue.
FCF margin1.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin4.8%Cash from operations / revenue.
Effective tax rate36.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)3.4%Net income / average total assets.
Return on invested capital (ROIC)21.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.1%Capital expenditures / revenue.
D&A / revenue4.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-0.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-0.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y2.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y2.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y2.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y-43.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-6.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y-0.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-19.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y4.0%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y5.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-63.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-23.3%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-12.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-64.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-21.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-6.8%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y18.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y2.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-7.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y79.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y15.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-16.5%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y6.1%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y15.4%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-5.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-1.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-0.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.83xCurrent assets / current liabilities.
Quick ratio0.43x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.10x(Cash + short-term investments) / current liabilities.
Debt / assets90.4%Total debt / total assets.
Liabilities / assets154.8%Total liabilities / total assets.
Net debt$699.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.96xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital-$48.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets8.0%(Goodwill + intangible assets) / total assets.
Tangible book value-$517.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover2.44xRevenue / average total assets.
Fixed asset turnover8.14xRevenue / average property, plant and equipment.
Inventory turnover43.1xCost of revenue / average inventory.
Days inventory8 days365 x average inventory / cost of revenue.
Receivables turnover20.8xRevenue / average receivables.
Days sales outstanding18 days365 x average receivables / revenue.
Days payables18 days365 x average accounts payable / cost of revenue.
Cash conversion cycle8 daysDays inventory + days sales outstanding - days payables.
FCF conversion124.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow64.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.83Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$59.38Revenue / diluted weighted shares.
FCF per share$1.03Free cash flow / diluted weighted shares.
Operating cash flow per share$2.87Cash from operations / diluted weighted shares.
Book value per share-$13.77Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$15.74Tangible book value / shares outstanding.
Cash per share$0.87(Cash + short-term investments) / shares outstanding.
Payout ratio223.1%Dividends paid / net income, when net income is positive.
Dividends / FCF179.7%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$643.6MShare price x shares outstanding.
Enterprise value$1.34BMarket cap + total debt - cash - short-term investments.
P/E23.3xMarket cap / net income. Only when net income is positive.
P/S0.33xMarket cap / revenue.
P/FCF18.8xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF6.78xMarket cap / cash from operations, when positive.
EV/Sales0.68xEnterprise value / revenue.
EV/EBIT15.9xEnterprise value / operating income, when both are positive.
EV/EBITDA7.60xEnterprise value / EBITDA, when both are positive.
EV/FCF39.2xEnterprise value / free cash flow, when both are positive.
FCF yield5.3%Free cash flow / market cap.
Earnings yield4.3%Net income / market cap (the inverse of P/E).
Dividend yield9.6%Dividends paid over the period / market cap.
Shareholder yield9.6%(Dividends paid + share buybacks) / market cap.
What was PAPA JOHNS INTERNATIONAL INC's revenue in fiscal 2025?

PAPA JOHNS INTERNATIONAL INC reported revenue of $2.05B for fiscal 2025, 0.3% lower than the year before.

Was PAPA JOHNS INTERNATIONAL INC profitable in fiscal 2025?

Yes. Net income was $30.5M, a net margin of 1.5%.

How much free cash flow did PAPA JOHNS INTERNATIONAL INC generate in fiscal 2025?

Cash from operations of $126.0M minus capital expenditures of $64.7M left free cash flow of $61.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PAPA JOHNS INTERNATIONAL INC